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There is a strong link between inflammation, infectious
agents, and nutritional status. Millions of people suffer from
chronic inflammatory diseases, and the incidence has signif-
icantly increased in recent years. Inflammation is a multifac-
torial biological and immunological response to different
injuries. Inflammation is initiated by several stimuli such as
pathogens, chemical irritants, nutritional imbalance, and
different cell injures. Inflammation is required in the body
process of healing. But, chronic inflammation can cause
severe and irreversible complications. Different chronic
inflammatory diseases include hepatic, colitis, gastrointesti-
nal, and neurodegenerative. Divers microbial (e.g., Helico-
bacter, Campylobacter, Clostridium, and Mycobacterium),
parasitic (e.g., protozoa, helminthes, and flatworms), and
viral (HPV, norovirus, and hepatitis B and C) are linked with
chronic inflammatory responses. Additionally, nutrition
imbalance and specific nutrients may influence immune
response,modulating infections, and inflammatory responses.
Crohn’s and ulcerative colitis are chronic inflammatory
bowel disease (IBD) and progressive complication with a
dysregulated gastrointestinal mucosal immune response in
patient toward intestinal microbiota. Pediatrics often mani-
fest with more severe Crohn’s complication than adults.
Crohn’s patients may eventually develop strictures and
malignancies. IL-17-A-producing T helper cells (Th17) have
a key role in provoking progression of disease by production
of proinflammatory cytokines which in turn required for
regeneration and protection of epithelial cells. Crohn’s
patients have increased production of IL-17 by T helper cells
and higher IL-17 mRNA expression at the mucosal level
and increased numbers of Th17 cells are associated with
endoscopic definition of disease activity. Unlike previous
studies, A. Dige et al. concluded that anti-TNFα antibody
therapy has no effect on the mucosal levels of IL-17A,
IL-21, and IL-22 or LP T cell production during early treat-
ment (first 4 weeks) in Crohn’s disease.
Composition of commensal microbiota can influence
autoimmune disease progress and persistence. The intestinal
microbiota is involved in triggering the immune system and
leading to intestinal inflammation. IBD patients suffer from
a dysbiosis, with decrease in diversity and abundance of some
beneficial commensal bacteria. For instance, significant
reductions have been reported in Bifidobacteria and Lactoba-
cillus in the IBD patients’ fecal content suggesting a therapeu-
tic application to normalize the gut flora in autoimmune
patients using probiotics. Recent study report that gut micro-
bial can translocate from gut into the organs as gut barrier
compromises and pathogenic T helper cells are evident in
the gut, liver, and lymphoid organs. Similarly, microbial are
also found in hepatic biopsies of autoimmune patients and
not in healthy counterparts. Bifico is a probiotic mixture of
Lactobacillus, Bifidobacterium, and Enterococcus. Previous
studies have demonstrated Bifico to improve colitis and
colitis-associated malignancy, pouchitis, diarrhea, and gastri-
tis in models. In addition, clinical trials have revealed thera-
peutic application for Bifico in Crohn’s and ulcerative
colitis patients. Bifico has been shown to elevate the
expression of colonic TJs and promote intestinal epithelial
barrier function in IL-10-deficient mice. In vitro experi-
ments also showed that Bifico, or single probiotic strains
(Bifidobacterium, Lactobacillus, or Enterococcus), increases
transepithelial electrical resistance and the expression of
Hindawi
Mediators of Inflammation
Volume 2018, Article ID 7160859, 4 pages
https://doi.org/10.1155/2018/7160859
TJs in Escherichia coli-treated Caco-2 monolayers. Bifico
significantly inhibited the secretion of proinflammatory
cytokines and reduced bacterial invasion and combination
of probiotics were more pronounced than single-strain pro-
biotics. Bifico was shown to have anti-inflammatory effect
to expand Tregs in mesenteric lymph nodes and disturbance
of Th1/Th2 cytokines in the colonic mucosa of TNBS-
induced colitis mice. However, the effect of Bifico on the
Tregs in intestinal tissue and peripheral blood has not been
reported. These experimental studies were performed in
active colitis induced with dextran sulfate sodium (DSS) to
explore the therapeutic effects of Bifico. Here, Y. Zhang
et al. used DSS-active colitis model to investigate Bifico effect
associated with local and systemic immune responses. This
study explored the protective effect of Bifico pretreating on
subsequent intestinal inflammation.
Acute pancreatitis (AP) is an acute and life-threatening
inflammatory disease that commonly damages peripancrea-
tic tissues and other distant organs. A consistent percentage
(about the 25%) of patients with severe acute pancreatitis
(SAP) develops into infected pancreatic necrosis and persis-
tent organ failure, contributing the most to AP mortality.
In fact the SAP, due to excessive release of inflammatory
factors and increased oxidative stress response, can cause
distant organ damage, especially acute lung injury. In addi-
tion, currently, there is no effective therapeutic strategy for
AP. For this purpose, Y. Li et al. used Cae-induced mild AP
(MAP) model and L-arginine-induced SAP model, to
investigate the role of naringenin (Nar) in AP and the
accompanying organ dysfunctions in mice as well as the
underlying mechanisms. Nar is a type of flavonoid, with
anti-inflammatory properties, organ-protective effects, and
antioxidative functions. They observed that the serum levels
of amylase, lipase, and cytokines and the malondialdehyde
(MDA) levels of pancreatic tissue were significantly decreased
in both MAP and SAP models after Nar treatment. In
contrast, glutathione peroxidase, glutathione reductase,
glutathione-S-transferase, total sulfhydryl, and nonprotein
sulfhydryl were markedly increased both in MAP and SAP
after Nar treatment. In addition, the injury in pancreatic
and pulmonary tissues was markedly improved as evidenced
by the inhibited expression of myeloperoxidase, nod-like
receptor protein 3, and interleukin-1β as well as the enhanced
expression of nuclear factor erythroid 2-related factor2/heme
oxygenase-1 in pancreatic tissues. So, they concluded that
Nar exerted protective effects on Cae-induced MAP and
L-arginine-induced SAP in mice, suggesting that Nar may
be a potential therapeutic intervention for AP.
Gut microbiota (GM) plays several crucial roles in host
physiology, influencing different relevant functions. GM
diversity is affected by diet and influences metabolic and
immune functions of the host’s physiology. Consequently, a
dysbiosis may be the cause or at least may lead to the progres-
sion of various pathologies such as infectious diseases, gas-
trointestinal cancers, IBD, and even obesity and diabetes.
Therefore, GM is an appropriate target for nutritional
intervention to improve health and phytochemicals (that
can influence GM) have recently been studied as adjuvants
for the treatment of obesity and inflammatory diseases.
L. Carrera-Quintanar et al. discussed the most recent evi-
dence indicating a relationship between the effects of different
phytochemicals and gut microbiota, affecting obesity and/or
inflammation. Authors focused on the effect of approximately
40 different phytochemical compounds, candidates for the
treatment of obesity and inflammatory diseases. They con-
cluded that several issues need to be resolved before natural
products can be effectively translated into the clinic. With
regard to the best source of bioactive molecules, the follow-
ing aspects should be considered: (a) whether it is better to
acquire them directly from diet food or from pharmacolog-
ical sources and (b) whether they should be used alone or
as a cotreatment in combination with approved drugs.
Therefore, it is urgent to develop specific clinical trials. In
addition, disadvantages of commercial nutraceutics’ prepa-
rations include the high variability in formulations, as well
as the dosage quantification and the different means of
administration. Finally, critical investigations are required
to optimize these phytochemical formulation and dosages
for possible future administration.
The digestive system plays an important part in patho-
genesis of infection by the human immunodeficiency virus
(HIV), which can infect hepatocytes, Kupffer cells, and
hepatic stellate cells, inducing the production of inflamma-
tory cytokines and favoring hepatic steatosis. Circulating
levels of different hepatic proteins (e.g., albumin, prealbumin,
and transferrin) decrease, increasing the mortality risk in
AIDS patients. L. Xu et al. evaluated whether the level of
butyrylcholinesterase (BchE) could be associated with the
progression/prognosis of AIDS patients. Evaluating a cohort
of 505 patients, the associations between BChE level and CD4
count, WHO stage, body mass index, and C-reactive protein
level, the authors concluded that BChE level is associated
with HIV/AIDS severity and is an independent risk factor
for increased mortality in AIDS patients.
Surgery is elective treatment for colorectal malignancy,
yet the morbidity rate following colorectal resection remains
as high as 24%–43%. Some of these postsurgical complica-
tions include tissue adhesions at the site of surgery, infec-
tions, anastomotic leakage, impaired bowel movement, and
malfunction as transient or prolonged postsurgical ileus if
not resolved after 5 days or recurrent after recovery. These
complications can delay recovery and increase the length
of hospitalization and acquired infections and medical
expenses. An effective biomarker to predict postsurgical ileus
and other complications can be useful for recovery in these
patients. G.S.A. Boersema et al. investigated a prospective
cohort trail for the association between the inflammatory
cytokines and the postoperative complications. The authors
studied 47 patients from which 34 (72%) recovered. From
13 patients (28%) who developed postsurgical ileus, 8 (20%)
recovered after 5 days and 5 patients (10%) developed
recurrent disease. The authors discuss the association of
different inflammatory cytokines involvement with postsur-
gical complications and reason IL-6 changes to predict the
infectious complications but not postsurgical ileus after
colorectal surgery. They concluded that IL-6 may be prom-
ising candidate to assist an early detection of the infections
following surgeries.
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Maresins, a group of lipid mediators, are biosynthe-
sized from docosahexaenoic acid which displays strong
anti-inflammatory and proresolving activity. Resolution of
inflammation is an active and highly regulated cellular and
biochemical process required to protect against inflamma-
tory complications. S. Tang et al. review the biological
actions, pathways, and mechanisms of maresins and their
roles in the resolution of inflammation in various disease
conditions including lung disease, vascular disease, obesity,
diabetes, and IBD. Authors concluded that maresins may
prevent neutrophil infiltration, enhance macrophage phago-
cytosis, inhibit nuclear factor-κB activation, and stimulate
tissue regeneration. Similar studies may provide new direc-
tions to discover maresin-related stable analogues to control
inflammation in the future.
IBD is a multifactorial inflammatory disease of the intes-
tine. Diet has long been suspected to contribute to the IBD
development and the Western dietary pattern, which is high
fat, high n-6 polyunsaturated fatty acids (PUFA), is associ-
ated with an increased IBD risk. N-3 PUFAs contain mostly
fish oil andhave anti-inflammatory properties. C.Charpentier
et al. investigated the dietary influence of fatty acid composi-
tion on 2,4,6-trinitrobenzen sulfonic acid- (TNBS-) induced
colitis. Rats were fed with diets varying in n-3/n-6/n-9 ratio
to reproduce dietary pattern from a pragmatic to a Western
diet. There were 4 groups with n-3/n-6/n-9 ratio 1 : 4 : 16,
1 : 1 : 4, 1 : 16 : 16, and 1 : 4 : 24, respectively. n-3/n-6/n-9 ratio
1 : 4 : 16 is recommended as a well-balanced control diet, and
1 : 1 : 4 was a target by dietary advice in a Japanese clinical
trial for IBD patients. 1 : 16 : 16 is considered comparable
to Western diet, and ratio 1 : 4 : 24 is comparable to the
Mediterranean diet. The results showed that compared to
the control diet, n-3 polyunsaturated fatty acids-rich diet
significantly decreased colon-inducible nitric oxide syn-
thase, cycloxygenase-2 expression, IL-6, and leukotriene
B4 production. The authors concluded that n-3 diet group
which showed n-3/n-6 ratio equals to 1 attenuated inflam-
matory markers in the colon that may contribute to par-
tially limit colitis genesis.
Formononetin is an isoflavone compound that has been
reported to possess anti-inflammatory properties. D. Wu
et al. investigated the effects of formononetin on DSS-
induced acute colitis in vivo and in vitro on tumor necrosis
factor-α-induced human colonic cell injury models. Mice
with colitis were intraperitoneal injected with different dos-
ages of formononetin. The main findings showed that formo-
nonetin administration relieved clinical symptoms of colitis,
mitigated colonic epithelial cell injury, and upregulated the
levels of colonic tight junction proteins ZO-1, claudin-1,
and occluding. In the in vitro study, the formononetin pre-
vented acute injury of human colonic cells by increasing
colonic tight junction proteins and decreasing inflamma-
tory cytokine expression. The mechanism may partly be
associated with NLRP3 inflammasome signaling inhibition,
as the NLRP3 pathway protein levels including NLRP3,
ASC, and interleukin-1β were downregulated in a dose-
dependent manner, in vivo and in vitro, when formononetin
was administered. The authors concluded that formonone-
tin could protect colonic epithelial cells from injury to
relieve the disease severity of colitis and may have poten-
tial to be used in the clinical prevention and treatment of
IBD in future.
Angiostrongylosis is an important food-borne diseases
and eosinophilic encephalitis in humans, caused by rat
gut nematode (rat lungworm). Outbreaks of eosinophilic
meningitis have been reported due to the consumption
of infected raw snails and vegetables’ juice. Angiostrongy-
lus invades the central nervous system and causes neurons’
demyelination, eosinophilic encephalitis, and meningoen-
cephalitis. An inflammatory response and surge of cytokines
such as IL-17 have been detected in the central nervous
system. IL-17 can induce Act1-mediated signaling cascades
in CNS resident cells (astrocytes, oligodendrocytes, and neu-
rons) might coordinately mediate CNS inflammation, demy-
elination, and neurodegeneration. But the mechanisms by
which IL-17 involves in the demyelination caused by this
nematode is not investigated. F. Ying et al. explore the role
of IL-17A on the demyelination and introduce IL-17A-
neutralizing antibody to protect against demyelination
caused by the parasite as a possible therapeutic option in
angiostrongylosis. In addition, iNOS inhibition is the possi-
ble mechanism for the therapeutic effect. This study provides
a new potential therapeutic alternative for demyelination
caused by Angiostrongylus cantonensis.
Alcohol consumption in excess causes extensive liver
injuries of fatty liver which progresses to hepatitis, fibrosis,
cirrhosis, and hepatocarcinoma. Ethanol increases NADH/
NAD+ ratio and promotes fatty acid synthesis and lipid
accumulation in liver cells. Further, it causes excessive oxi-
dative stress and increases CYP2E1 activity. In addition,
ethanol increases endotoxin bypass from leaky gut which
triggers Kupffer’s cell activation and inflammatory pro-
cesses. There is an emerging theory that chronic ethanol
abuse damages the tight junction structure in intestinal
epithelial cells results in bacterial translocation from the
intestines into the in vivo circulation to induce hepatic
inflammation. Indeed, patients with alcoholic liver disease
have higher levels of endotoxin and intestinal barrier dis-
turbances caused by ethanol are the major source of endo-
toxemia in these patients. Different source of dietary fat
can effect progression of liver injury as diets rich in satu-
rated fatty acids or medium chain triglycerides protect
against ethanol-induced liver injury in rodents. In contrast,
polyunsaturated fatty acids can provoke liver injury. How-
ever, there were some limitations of these previous studies
such as only one type of fat was used in each experimental
diet, but the effects on other organs or tissues were not
explored. Studies have demonstrated that fish oil, which
is rich in n-3 polyunsaturated fatty acids, eicosapentaenoic
acid, and docosahexaenoic acid, can provide immune reg-
ulation, vascular protection, and lipid metabolism modula-
tion. However, the mechanism by which oil can modify
intestinal integrity in alcoholic liver disease is not well
understood. Further, some studies reveal fish oil and olive
oil to improve the fecal microbiota under ethanol expo-
sure, but the effects on intestinal pathological changes in
ethanol-fed rats are still unclear. Y.-W. Chien et al.
explored whether fish oil can provoke hepatoprotective
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effects in ethanol-fed rats by means of maintaining the
epithelial barrier function in the intestines and further inhi-
biting endotoxin in circulation. Authors concluded that
the chronic ethanol can elevate plasma endotoxin concen-
trations and trigger inflammatory responses which can
result in liver injury. Substitution of fish oil for olive oil
inhibited the appearance of endotoxin in the circulation
under ethanol exposure; thus, it decreased inflammatory
responses and exerted a hepatoprotective potential in rats
under chronic ethanol feeding. However, the mechanism
of decreased plasma endotoxin levels by fish oil supple-
mentation alone might not be enough to improve intesti-
nal structural integrity.
About 30–40% of chronic inflammatory disease patients
use some form of complementary and alternative medicine,
including Chinese traditional herbal therapies. It is esti-
mated that 12 million tons of herbal wastes is produced each
year by about 1,500 Chinese traditional herbal medicine
enterprises in China. During process, the active ingredients
are extracted from plants, and the waste which still contains
about 30%–50% of the medicinal active ingredient is buried
or burned which becomes major source of environmental
pollutant in water and in air. Fermentation by digestive
enzymatic reaction utilizing cellulase, protease, pectinase,
and lipase can degrade plant cell wall and expose intercellu-
lar organelles to assist in extraction of active ingredients. In
addition, certain probiotics can improve digestive process
and protect against malabsorption, malnutrition, and diar-
rhea. Antibiotic-associated diarrhea is a frequent side effect
caused by altered gut microbiota which supports pathogen
growth. F. Meng et al. used probiotics to ferment the
herbal residues in Jianweixiaoshi, a mixture of herbal rem-
edy used for diarrhea, and the reason for this compound
may become as therapeutic potential against antibiotic-
associated diarrhea, as well as to reduce the waste products
from herbal residues produced by traditional herbal medi-
cine enterprises.
Flowers of Osmanthus fragrans (O. fragrans) and Chry-
santhemum morifolium (C. morifolium) are commonly used
as folk medicine and additives for tea and beverages. The
active components isolated from these flowers contain many
phenolic compounds that have been shown to have anti-
inflammatory and antioxidant properties. Lipotoxicity occurs
when excessive harmful lipid accumulates in cells leading
to cellular dysfunction and disruption of tissue function.
Lipotoxicity plays a critical role in the pathogenesis of
nonalcoholic fatty liver disease and renal diseases. P.-J.
Tsai et al. investigated the effects of methanolic flower
extracts of O. fragrans and C. morifolium against free fatty
acid-induced lipotoxicity in hepatocytes and renal glomer-
ular mesangial cells. The results showed that both extracts
inhibited free fatty acid-induced hepatocyte triglyceride
accumulation and suppressed mRNA expression of inflam-
matory cytokines when hepatocytes were stimulated with
lipopolysaccharide-treated monocytes. Also, flowers extracts
of O. fragrans and C. morifolium effectively inhibited oleate-
induced cellular lipid accumulation and overexpression of
fibronectin in mesangial cells. The authors concluded that
these flower extracts possess hepato- and renal-protective
activity by inhibiting hepatic fat load and inflammation
and mesangial extracellular matrix formation. These find-
ings imply that flowers of O. fragrans and C. morifolium
may have potential to protect against nonalcoholic steato-
hepatitis and renal fibrosis.
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